> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-153/
- Published: 2017-10-22T12:00:00.000Z
- Updated: 2026-09-14T22:57:27.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139936

[**FDA Extends Deadline for Lab Test Identifiers in Applications**](https://www.fdaweb.com/fda-extends-deadline-for-lab-test-identifiers-in-applications/)  
*Federal Register* notice: FDA announces an extension of the deadline to provide Logical Observation Identifiers Names and Codes for clinical laboratory test results in investigational study data provided in regulatory submissions submitted to CDER and CBER. 10/20/2017

[**Class 2 for Microbial Pathogen Detectors In Cerebrospinal Fluid**](https://www.fdaweb.com/class-2-for-microbial-pathogen-detectors-in-cerebrospinal-fluid/)  
*Federal Register* notice: FDA classifies devices that detect and identify microbial pathogen nucleic acids in cerebrospinal fluid into class 2 (special controls). 10/20/2017

[**Draft Guide on Generic Tiotropium Bromide Products**](https://www.fdaweb.com/draft-guide-on-generic-tiotropium-bromide-products/)  
*Federal Register* notice: FDA makes available a draft guidance for industry on generic tiotropium bromide inhalation powder. 10/20/2017

[**3 Draft Guides on Generic Inhalation Drugs**](https://www.fdaweb.com/3-draft-guides-on-generic-inhalation-drugs/)  
*Federal Register* notice: FDA makes available three draft guidances for industry on generic salmeterol xinafoate inhalation powder, fluticasone propionate inhalation aerosol, and fluticasone propionate inhalation powder. 10/20/2017

[**CDRH Seeks Experiential Learning Partners**](https://www.fdaweb.com/cdrh-seeks-experiential-learning-partners/)  
*Federal Register* notice: CDRH announces its 2018 Experiential Learning Program. 10/18/2017

[**Class 2 Designation for Organophosphate Test System**](https://www.fdaweb.com/class-2-designation-for-organophosphate-test-system/)  
*Federal Register* notice: FDA classifies the organophosphate test system into Class 2 (special controls). 10/18/2017

[**Comments Sought on Device Tracking Collection**](https://www.fdaweb.com/comments-sought-on-device-tracking-collection/)  
*Federal Register* notice: FDA seeks comments on an information collection extension request for “Medical Devices; Device Tracking — 21 CFR Part 821.” 10/18/2017

[**Certain Devices for Detecting Microbial Pathogens into Class 2**](https://www.fdaweb.com/certain-devices-for-detecting-microbial-pathogens-into-class-2/)  
*Federal Register* notice: FDA classifies nucleic acid-based devices for the amplification, detection, and identification of microbial pathogens directly from whole blood specimens into Class 2 (special controls). 10/17/2017